πŸ‡ΊπŸ‡Έ FDA
Patent

US 9464060

Compounds

granted A61KA61K31/195A61K31/277

Quick answer

US patent 9464060 (Compounds) held by Takeda Pharmaceutical Company Limited expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/195, A61K31/277, A61K31/44, A61K31/505